AAAAAA

   
Results: 1-10 |
Results: 10
TREATMENT OF ANEMIA IN MYELODYSPLASTIC SYNDROMES WITH GRANULOCYTE-COLONY-STIMULATING FACTOR PLUS ERYTHROPOIETIN - RESULTS FROM A RANDOMIZEDPHASE-II STUDY AND LONG-TERM FOLLOW-UP OF 71 PATIENTS
Authors: HELLSTROMLINDBERG E AHLGREN T BEGUIN Y CARLSSON M CARNESKOG J DAHL IM DYBEDAL I GRIMFORS G KANTERLEWENSOHN L LINDER O LUTHMAN M LOFVENBERG E NILSSONEHLE H SAMUELSSON J TANGEN JM WINQVIST I OBERG G OSTERBORG A OST A
Citation: E. Hellstromlindberg et al., TREATMENT OF ANEMIA IN MYELODYSPLASTIC SYNDROMES WITH GRANULOCYTE-COLONY-STIMULATING FACTOR PLUS ERYTHROPOIETIN - RESULTS FROM A RANDOMIZEDPHASE-II STUDY AND LONG-TERM FOLLOW-UP OF 71 PATIENTS, Blood, 92(1), 1998, pp. 68-75
THE DURATION OF ORAL ANTICOAGULANT-THERAPY AFTER A 2ND EPISODE OF VENOUS THROMBOEMBOLISM
Authors: SCHULMAN S GRANQVIST S HOLMSTROM M CARLSSON A LINDMARKER P NICOL P EKLUND SG NORDLANDER S LARFARS G LEIJD B LINDER O LOOGNA E GUSTAFSSON C GRONDAHL A RHEDIN AS TORNEBOHM E LOCKNER D JOHNSSON H KOBOSKO J MALMROS B ARCINI N SAAW J STIG R VIERING S LJUNGBERG B WILHELMSSON S OHLSSON A WALTER H MALMQVIST K ALKHALILI F PETRESCU A BROHULT J HULTING J SVENSSON E DAHLIN L BOBERG J MARJANOVICS B JONSSON KA MALM C HJORTH M LINDGREN A FAGRELL B KALLNER M WADMAN B SNYDER M
Citation: S. Schulman et al., THE DURATION OF ORAL ANTICOAGULANT-THERAPY AFTER A 2ND EPISODE OF VENOUS THROMBOEMBOLISM, The New England journal of medicine, 336(6), 1997, pp. 393-398
INTENSIVE TREATMENT IN ORDER TO MINIMIZE THE PH-POSITIVE CLONE IN CML
Authors: SIMONSSON B OBERG G LINDER O BJORKHOLM M CARNESKOG J STENKE L KARLE H LANNGNIELSEN J LOFVENBERG E MALM C PAUL C TURESSON I UDEN AM VILEN L WEISBJERRUM O
Citation: B. Simonsson et al., INTENSIVE TREATMENT IN ORDER TO MINIMIZE THE PH-POSITIVE CLONE IN CML, Blood, 90(10), 1997, pp. 1744-1744
THE SIGNIFICANCE OF HYPOFIBRINOLYSIS FOR THE RISK OF RECURRENCE OF VENOUS THROMBOEMBOLISM
Authors: SCHULMAN S WIMAN B CARLSSON A GUSTAFSSON C GRONDAHL A RHEDIN AS TORNEBOHM E JOHANSSON M LOCKNER D LINDMARKER P JOHNSSON H NICOL P KOBOSKO J MALMROS B ARCINI N SAAW J LOOGNA E STIG R VIERING S LJUNGBERG B WILHELMSSON S OHLSSON A WALTER H MALMQVIST K ALKHALILI F LEIJD B PETRESCU A BROHULT J LARFARS G HULTING J EKLUND SG SVENSSON E DAHLIN L BOBERG J NORDLANDER S MARJANOVICS B LINDER O JONSSON KA MALM C HJORTH M FAGRELL B KALLNER M GRANQVIST S EGBERG N SCHULMAN S WADMAN B SNYDER M
Citation: S. Schulman et al., THE SIGNIFICANCE OF HYPOFIBRINOLYSIS FOR THE RISK OF RECURRENCE OF VENOUS THROMBOEMBOLISM, Thrombosis and haemostasis, 75(4), 1996, pp. 607-611
TREATMENT OF THE ANEMIA IN MDS WITH G-CSF AND EPO - FINAL REPORT FROMA RANDOMIZED PHASE-II STUDY
Authors: HELLSTROMLINDBERG E TANGEN JM GRIMFORS G LINDEMALM C CARLSSON M OBERG G LOWENBERG E LINDER O DYBEDAL I DAHL IM NILSSONEHLE H AHLGREN T WINQUIST I CARNESKOG J LUTHMAN M
Citation: E. Hellstromlindberg et al., TREATMENT OF THE ANEMIA IN MDS WITH G-CSF AND EPO - FINAL REPORT FROMA RANDOMIZED PHASE-II STUDY, Blood, 88(10), 1996, pp. 1805-1805
A COMPARISON OF 6 WEEKS WITH 6 MONTHS OF ORAL ANTICOAGULANT-THERAPY AFTER A FIRST EPISODE OF VENOUS THROMBOEMBOLISM
Authors: SCHULMAN S RHEDIN AS LINDMARKER P CARLSSON A LARFARS G NICOL P LOOGNA E SVENSSON E LJUNGBERG B WALTER H VIERING S NORDLANDER S LEIJD B JONSSON KA HJORTH M LINDER O BOBERG J GUSTAFSSON C GRONDAHL A TORNEBOHM E JOHANSSON M LOCKNER D JOHNSSON H KOBOSKO J MALMROS B ARCINI N SAAW J STIG R WILHELMSSON S OHLSSON A MALMQVIST K ALKHALILI F PETRESCU A BROHULT J HULTING J EKLUND SG DAHLIN L MARJANOVICS B MALM C LINDGREN A FAGRELL B KALLNER M GRANQVIST S WIMAN B EGBERG N WADMAN B SNYDER M
Citation: S. Schulman et al., A COMPARISON OF 6 WEEKS WITH 6 MONTHS OF ORAL ANTICOAGULANT-THERAPY AFTER A FIRST EPISODE OF VENOUS THROMBOEMBOLISM, The New England journal of medicine, 332(25), 1995, pp. 1661-1665
QUALITY OF ORAL ANTICOAGULANT CONTROL AND TREATMENT IN SWEDEN
Authors: SCHULMAN S CARLSSON A GUSTAFSSON C GRONDAHL A RHEDIN AS TORNEBOHM E JOHANSSON M LOCKNER D LINDMARKER P JOHNSSON H NICOL P KOBOSKO J MALMROS B ARCINI N SAAW J LOOGNA E STIG R VIERING S LJUNGBERG B WILHELMSSON S OHLSSON A WALTER H MALMQVIST K ALKHALILI F LEIJD B PETRESCU A BROHULT J LARFARS G HULTING J EKLUND SG SVENSSON E DAHLIN L BOBERG J NORDLANDER S MARJANOVICS B LINDER O JONSSON KA MALM C HJORT M FAGRELL B KALLNER M GRANQVIST S WIMAN B EGBERG N
Citation: S. Schulman et al., QUALITY OF ORAL ANTICOAGULANT CONTROL AND TREATMENT IN SWEDEN, Journal of internal medicine, 236(2), 1994, pp. 143-152
SYNERGISTIC EFFECT OF G-CSF AND EPO ON THE ANEMIA IN PATIENTS WITH MDS - EVIDENCE FOR INCREASED ERYTHROPOIETIC EFFECTIVENESS RATHER THAN EXPANSION
Authors: HELLSTROMLINDBERG E CARLSSON M CARNESKOG J DAHL IM DYBEDAL I GRIMFORS G LINDEMALM C LINDER O LOFVENBERG E NILSSONEHLE H TANGEN JM TURESSON I WINQVIST I OBERG G BEGIN Y OST A
Citation: E. Hellstromlindberg et al., SYNERGISTIC EFFECT OF G-CSF AND EPO ON THE ANEMIA IN PATIENTS WITH MDS - EVIDENCE FOR INCREASED ERYTHROPOIETIC EFFECTIVENESS RATHER THAN EXPANSION, Blood, 84(10), 1994, pp. 10000317-10000317
ALPHA-INTERFERON (WELLFERON), CYCLOPHOSPHAMIDE AND HIGH-DOSE BETAMETHASONE (CIB) FOLLOWED BY GM-CSF FOR TREATMENT OF MULTIPLE-MYELOMA - A PILOT-STUDY
Authors: OSTERBORG A BJORKHOLM M BJOREMAN M BRENNING G CARLSON K CELSING F GAHRTON G GRIMFORS G GYLLENHAMMAR H HAST R JOHANSSON B JULIUSSON G JARNMARK M KIMBY E LERNER R LINDEMALM C LINDER O OHRLING M PAUL C SIMONSSON B SKARBERG KF SMEDMYR B STRANDER H SVEDMYR E TIDEFELT U UDEN AM WERNER B OSBY E MELLSTEDT H
Citation: A. Osterborg et al., ALPHA-INTERFERON (WELLFERON), CYCLOPHOSPHAMIDE AND HIGH-DOSE BETAMETHASONE (CIB) FOLLOWED BY GM-CSF FOR TREATMENT OF MULTIPLE-MYELOMA - A PILOT-STUDY, Blood, 84(10), 1994, pp. 10000657-10000657
ETOPOSIDE, DOXORUBICIN, CYCLOPHOSPHAMIDE AND HIGH-DOSE BETAMETHASONE (EACB) AS OUTPATIENT SALVAGE THERAPY FOR REFRACTORY MULTIPLE-MYELOMA
Authors: OHRLING M BJORKHOLM M OSTERBORG A JULIUSSON G BJOREMAN M BRENNING G CARLSON K CELSING F GAHRTON G GRIMFORS G GRUBER A GYLLENHAMMAR H HAST R JOHANSSON B JARNMARK M KIMBY E LERNER R LINDER O MERK K PAUL C SIMONSSON B SMEDMYR B SVEDMYR E STALFELT AM UDEN AM OSBY E MELLSTEDT H
Citation: M. Ohrling et al., ETOPOSIDE, DOXORUBICIN, CYCLOPHOSPHAMIDE AND HIGH-DOSE BETAMETHASONE (EACB) AS OUTPATIENT SALVAGE THERAPY FOR REFRACTORY MULTIPLE-MYELOMA, European journal of haematology, 51(1), 1993, pp. 45-49
Risultati: 1-10 |